Back to search
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 De…
The primary purpose of ENERGY 2 (Study INZ701-105) is to assess the efficacy and safety of INZ-701 in infants with ENPP1 Deficiency.